TOP TIERMARKET NEWSWIRE
News & sentiment

VYNE THERAPEUTICS IN (VYNE) — News & AI sentiment

VYNE THERAPEUTICS IN (VYNE) news roundup. 3 stories in the past week, 15 over 30 days. Average 30-day sentiment is 42.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
3
avg sentiment 47/100
30d stories
15
avg sentiment 42.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

Latest stories on VYNE

Yarrow Bioscience, Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
1d ago
3d ago
6d ago
Jul 21
Jul 21
Jul 21
VYNE Therapeutics Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
Jul 21
Jul 21
VYNE Therapeutics Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
Jul 18
VYNE Therapeutics Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
Jul 14
Jul 13
Jul 13
VYNE Therapeutics Inc. (VYNE) files 8-K
SEC 8-K50 · neutralgeneral
Jul 10
Jul 10
Jul 10
May 21
Open VYNE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →